Citius Pharmaceuticals (CTXR) Research & Development (2013 - 2026)
Citius Pharmaceuticals' Research & Development came in at $1.05 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 35.0% from $1.62 million a year earlier and down 35.5% from the prior quarter.
Citius Pharmaceuticals (CTXR) Research & Development (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Citius Pharmaceuticals reported Research & Development of $5.93 million, down 43.2% year-over-year; for FY2025 (ended Sep 30, 2025), it was $9.16 million, down 23.1% from FY2024.
- Research & Development has declined in each of the last three fiscal years, though with a five-year compound annual growth rate of 0.8% (FY2020 to FY2025).
- Going back by fiscal year, Research & Development was $11.91 million in FY2024 (-19.7%), $14.82 million in FY2023 (-16.1%), $17.66 million in FY2022 (+44.2%) and $12.24 million in FY2021 (+38.9%).
- The fiscal Q3 2026 figure represents the lowest quarterly Research & Development since fiscal Q4 2019.
- Year-over-year, Research & Development has declined for five consecutive quarters, with an average decline of 26.8% over the last eight quarters.
- The fastest year-over-year change in Research & Development over five years came in fiscal Q2 2022 (growth of 122.5%), and the weakest in fiscal Q2 2026 (a decline of 56.6%).
- Business Quant data shows CTXR's Research & Development at $1.63 million (Q2 2026), $1.6 million (Q1 2026) and $1.64 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Citius Pharmaceuticals | 9.70 Mn | -23.87 Mn | 1.00 Mn | 1.05 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.05 Mn |
| Mar 31, 2026 | 1.63 Mn |
| Dec 31, 2025 | 1.60 Mn |
| Sep 30, 2025 | 1.64 Mn |
| Jun 30, 2025 | 1.62 Mn |
| Mar 31, 2025 | 3.77 Mn |
| Dec 31, 2024 | 2.13 Mn |
| Sep 30, 2024 | 2.91 Mn |
| Jun 30, 2024 | 2.76 Mn |
| Mar 31, 2024 | 3.61 Mn |
| Dec 31, 2023 | 2.62 Mn |
| Sep 30, 2023 | 2.88 Mn |
| Jun 30, 2023 | 3.76 Mn |
| Mar 31, 2023 | 4.73 Mn |
| Dec 31, 2022 | 3.45 Mn |
| Sep 30, 2022 | 3.86 Mn |
| Jun 30, 2022 | 4.89 Mn |
| Mar 31, 2022 | 3.45 Mn |
| Dec 31, 2021 | 5.46 Mn |
| Sep 30, 2021 | 2.29 Mn |
Citius Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CTXR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CTXR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CTXR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();